Hypogonadism Clinical Trials

Find Hypogonadism Clinical Trials Near You

Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality - Have Anything Changed the Past 15 Years?

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Several international studies indicate that men with reduced semen quality often feel overlooked in the context of fertility treatment. Men who undergo fertility treatment due to their own infertility, exhibit increased concern and experience more negative emotions such as loss, stigmatization, and low self-esteem - more so than men undergoing fertility treatment for other reasons. Since 2008, there has been limited research on the experiences of male patients with infertility in Denmark. Furthermore, there is generally very little knowledge regarding the testosterone levels (hypogonadism) of male infertile patients and its association with quality of life. Thus, there is a lack of updated insight into how infertile men experience their situation today. Additionally, the present study finds it relevant to examine whether men's needs and experiences in interactions with health professionals have changed over the past 15 years.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: t
View:

• ICSI treatment caused by reduced semen quality, language (danish)

Locations
Other Locations
Denmark
Regionshospitalet
RECRUITING
Skive
Time Frame
Start Date: 2026-02-13
Estimated Completion Date: 2029-01-15
Participants
Target number of participants: 400
Treatments
Infertile males
Males with reduced semen quality according to WHO 2021 6th edition
Fertile males
Males normal semen quality according to WHO 2021 6th edition
Related Therapeutic Areas
Sponsors
Leads: Peter Humaidan

This content was sourced from clinicaltrials.gov